{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:54:43Z","timestamp":1793861683207,"version":"4.6.1"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jad.2024.02.038","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:31:50Z","timestamp":1707975110000},"page":"171-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Sex differences in effectiveness and adverse effects of mood stabilizers and antipsychotics: A systematic review"],"prefix":"10.1016","volume":"352","author":[{"given":"Mete","family":"Ercis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Sanchez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Solares-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah K.","family":"Betcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"Veldic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Ozerdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.02.038_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/09540261.2010.515205","article-title":"Sex differences in schizophrenia","volume":"22","author":"Abel","year":"2010","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-244X-3-4","article-title":"Risk factors of thyroid abnormalities in bipolar patients receiving lithium: a case control study","volume":"3","author":"Ahmadi-Abhari","year":"2003","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/0269881105053306","article-title":"Influence of age and gender on risperidone plasma concentrations","volume":"19","author":"Aichhorn","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb5010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02190085","article-title":"Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics","volume":"240","author":"Altamura","year":"1990","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.02.038_bb5015","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.4088\/JCP.v66n1118","article-title":"Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder","volume":"66","author":"Andersen","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12991-015-0075-x","article-title":"Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey","volume":"14","author":"Anderson","year":"2015","journal-title":"Ann. General Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0020","series-title":"JBI Manual for Evidence Synthesis. JBI","year":"2020"},{"key":"10.1016\/j.jad.2024.02.038_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-244X-5-3","article-title":"Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia","volume":"5","author":"Ascher-Svanum","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0030","first-page":"982","article-title":"Smoking and suicidality in subjects with bipolar disorder: results from the National Epidemiologic Survey on alcohol and related conditions (NESARC)","volume":"30","author":"Baek","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2024.02.038_bb0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1399-5618.2005.00237.x","article-title":"Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants","volume":"7","author":"Baldassano","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.02.038_bb0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.jcp.0000085410.08426.9a","article-title":"Olanzapine versus placebo in acute mania: treatment responses in subgroups","volume":"23","author":"Baldessarini","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.jcp.0000185423.15891.02","article-title":"Sex differences in the subjective tolerability of antipsychotic drugs","volume":"25","author":"Barbui","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb5025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2006.09.025","article-title":"Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study","volume":"90","author":"Bobes","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0050","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.str.0000442009.06663.48","article-title":"Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Bushnell","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jad.2024.02.038_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004714-200304000-00003","article-title":"Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine","volume":"23","author":"Carrillo","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0920-9964(91)90029-Q","article-title":"Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia","volume":"4","author":"Casey","year":"1991","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/acps.12794","article-title":"Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine","volume":"136","author":"Castberg","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.02.038_bb5030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.schres.2015.10.013","article-title":"Gender differences in the treatment of first-episode schizophrenia: results from the European First Episode Schizophrenia Trial","volume":"169","author":"Ceskova","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0070","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2024.02.038_bb5035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0327(99)00064-6","article-title":"A control study of the cutaneous side effects of chronic lithium therapy","volume":"57","author":"Chan","year":"2000","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2024.02.038_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-12-47","article-title":"Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes","volume":"12","author":"Chen","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.psychres.2010.07.054","article-title":"Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics","volume":"186","author":"Chen","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0085","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF03348863","article-title":"Thyroid autoimmunity and female gender","volume":"16","author":"Chiovato","year":"1993","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.jad.2024.02.038_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00430747","article-title":"Pimozide in the treatment of newly admitted schizophrenic patients","volume":"76","author":"Chouinard","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2024.02.038_bb5040","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0269881116654698","article-title":"Early predictors of a clinical response at 8 weeks in patients with first-episode psychosis treated with paliperidone ER","volume":"30","author":"Chung","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/509282a","article-title":"Policy: NIH to balance sex in cell and animal studies","volume":"509","author":"Clayton","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jad.2024.02.038_bb0100","doi-asserted-by":"crossref","unstructured":"Cleare, A., Pariante, C.M., Young, A.H., Anderson, I.M., Christmas, D., Cowen, P.J., Dickens, C., Ferrier, I.N., Geddes, J., Gilbody, S., Haddad, P.M., Katona, C., Lewis, G., Malizia, A., McAllister-Williams, R.H., Ramchandani, P., Scott, J., Taylor, D., Uher, R., Members of the Consfensus, M., 2015. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J. Psychopharmacol. 29, 459\u2013525.","DOI":"10.1177\/0269881115581093"},{"key":"10.1016\/j.jad.2024.02.038_bb0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/0269881106069637","article-title":"Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities","volume":"21","author":"Cooper","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb0110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1742-7843.2009.00516.x","article-title":"Sex differences in animal models of depression and antidepressant response","volume":"106","author":"Dalla","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jad.2024.02.038_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2024.02.038_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.05.033","article-title":"Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics","volume":"168","author":"de Leon","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2024.02.038_bb5045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/phar.1260","article-title":"Intramuscular aripiprazole in the acute management of psychomotor agitation","volume":"33","author":"De Filippis","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jad.2024.02.038_bb0125","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.4088\/JCP.13m08400","article-title":"A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures","volume":"74","author":"Deligiannidis","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/09540261.2010.514601","article-title":"Is sex important? Gender differences in bipolar disorder","volume":"22","author":"Diflorio","year":"2010","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.psychres.2019.02.017","article-title":"Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2\/3 receptor blockade - an exploratory study","volume":"274","author":"During","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0140","first-page":"23","article-title":"Predictors of non-stabilization during the combination therapy of lithium and divalproex in rapid cycling bipolar disorder: a post-hoc analysis of two studies","volume":"43","author":"Gao","year":"2010","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2024.02.038_bb5050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpsychires.2019.05.004","article-title":"Antipsychotic-induced weight gain and birth weight in psychosis: a fetal programming model","volume":"115","author":"Garriga","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"9","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5055","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jpsychires.2008.11.001","article-title":"Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course","volume":"43","author":"Gebhardt","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb5060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pnpbp.2010.08.029","article-title":"Sociodemographic and treatment related variables are poor predictors of haloperidol induced motor side effects","volume":"35","author":"Giegling","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-1781(02)00028-8","article-title":"Sex differences in clinical response to olanzapine compared with haloperidol","volume":"110","author":"Goldstein","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12891-019-2619-8","article-title":"Preoperative opioid use is associated with worse patient outcomes after Total joint arthroplasty: a systematic review and meta-analysis","volume":"20","author":"Goplen","year":"2019","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.jad.2024.02.038_bb0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11920-017-0809-3","article-title":"Valproic acid in women and girls of childbearing age","volume":"19","author":"Gotlib","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2024.02.038_bb5065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1139\/jpn.0213","article-title":"Lithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: sex differences","volume":"27","author":"Henry","year":"2002","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2024.02.038_bb0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41537-021-00170-3","article-title":"Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study","volume":"7","author":"Hoekstra","year":"2021","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.jad.2024.02.038_bb0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/pds.4155","article-title":"Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden","volume":"26","author":"Holm","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2024.02.038_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1600-0447.2003.00251.x","article-title":"Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis","volume":"109","author":"Huber","year":"2004","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.02.038_bb5070","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/08039488.2017.1334821","article-title":"Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland","volume":"71","author":"Ingimarsson","year":"2017","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0180","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pnpbp.2017.11.004","article-title":"Side effect burden of antipsychotic drugs in real life - impact of gender and polypharmacy","volume":"82","author":"Iversen","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5075","first-page":"39","article-title":"Weight gain with olanzapine: drug, gender or age? Indian","volume":"48","author":"Jain","year":"2006","journal-title":"J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/schbul\/19.2.303","article-title":"Tardive dyskinesia","volume":"19","author":"Jeste","year":"1993","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jad.2024.02.038_bb5080","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1600-0447.1990.tb05493.x","article-title":"Non-right-handedness and maleness correlate with tardive dyskinesia among patients taking neuroleptics","volume":"81","author":"Joseph","year":"1990","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.02.038_bb0190","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus","volume":"37","author":"Kautzky-Willer","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jad.2024.02.038_bb0195","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2020.177901","article-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","volume":"177","author":"Keepers","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(99)00053-5","article-title":"Differential olanzapine plasma concentrations by sex in a fixed-dose study","volume":"40","author":"Kelly","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2753.2010.01591.x","article-title":"A systematic approach for uptake of evidence on sex-specific issues in guidelines--a pilot study","volume":"18","author":"Keuken","year":"2012","journal-title":"J. Eval. Clin. Pract."},{"key":"10.1016\/j.jad.2024.02.038_bb0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pnpbp.2011.11.016","article-title":"Sexual dysfunction and hyperprolactinemia in Japanese schizophrenic patients taking antipsychotics","volume":"37","author":"Kikuchi","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jad.2005.03.010","article-title":"A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients","volume":"87","author":"Kirov","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.02.038_bb5090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.archger.2007.09.005","article-title":"Antipsychotic treatment and the prevalence of diabetes among elderly patients in psychiatric rehabilitation","volume":"48","author":"Klebovich","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.jad.2024.02.038_bb5095","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1176\/ajp.146.3.387","article-title":"The Shanghai 800: prevalence of tardive dyskinesia in a Chinese psychiatric hospital","volume":"146","author":"Ko","year":"1989","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-3223(86)90143-5","article-title":"Tardive dyskinesia in schizophrenics under 60 years of age","volume":"21","author":"Kolakowska","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.20538\/1682-0363-2019-3-62-71","article-title":"Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia","volume":"18","author":"Kornetova","year":"2019","journal-title":"Byulleten Sib. Med."},{"key":"10.1016\/j.jad.2024.02.038_bb0215","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/dc10-0942","article-title":"Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk","volume":"33","author":"Kuk","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jad.2024.02.038_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235365","article-title":"Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma medical center, psychiatry clinic","volume":"15","author":"Kumsa","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2024.02.038_bb5110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.64719\/pb.4358","article-title":"Sex differences in antipsychotic related metabolic functioning in schizophrenia spectrum disorders","volume":"47","author":"Kraal","year":"2017","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2024.02.038_bb5115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bdi.12275","article-title":"A cross-sectional study of thyroid function in 66 patients with bipolar disorder receiving lithium for 10-44 years","volume":"17","author":"Kraszewska","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.02.038_bb0225","first-page":"227","article-title":"Effect of lithium maintenance therapy on thyroid and parathyroid function","volume":"24","author":"Kusalic","year":"1999","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2024.02.038_bb5120","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/070674370104600608","article-title":"Risperidone treatment of outpatients with schizophrenia: no evidence of sex differences in treatment response","volume":"46","author":"Labelle","year":"2001","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2024.02.038_bb5125","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4088\/JCP.v66n0713","article-title":"Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates","volume":"66","author":"Lamberti","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004714-200208000-00004","article-title":"Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics","volume":"22","author":"Lane","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb5135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.jcp.0000203196.65710.2b","article-title":"Risperidone-related weight gain: genetic and nongenetic predictors","volume":"26","author":"Lane","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb0230","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/acps.12030","article-title":"Psychopathological long-term outcome of schizophrenia -- a review","volume":"127","author":"Lang","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.02.038_bb0235","first-page":"995","article-title":"Tardive dyskinesia: determinants of temporal dynamics of its emergence","volume":"29","author":"Latalova","year":"2008","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.jad.2024.02.038_bb5140","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.pnpbp.2005.11.037","article-title":"The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients","volume":"30","author":"Lee","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12877-016-0202-9","article-title":"Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome","volume":"16","author":"Lee","year":"2016","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.jad.2024.02.038_bb0245","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.pnpbp.2010.12.003","article-title":"A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone","volume":"35","author":"Lee","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0250","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41386-018-0156-z","article-title":"Sex differences in antidepressant efficacy","volume":"44","author":"LeGates","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2024.02.038_bb0255","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/acps.13530","article-title":"Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: a meta\u2010analysis of randomized, double\u2010blind, placebo\u2010controlled trials","volume":"147","author":"Li","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.02.038_bb5150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11011-014-9587-3","article-title":"Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics?","volume":"30","author":"Lin","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jad.2024.02.038_bb5155","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1176\/jnp.13.3.399","article-title":"Relationship of gender and age at onset of schizophrenia to severity of dyskinesia","volume":"13","author":"Lindamer","year":"2001","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.02.038_bb0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jpsychires.2006.07.016","article-title":"Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapy","volume":"41","author":"Lipkovich","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb5160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/YIC.0000000000000207","article-title":"Pharmacotherapy for primary delusional jealousy, a retrospective observational study of 32 cases with Othello syndrome","volume":"33","author":"Liu","year":"2018","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb5165","first-page":"300","article-title":"Hippocampal subfield volumes and change in body mass over 12 months of treatment in first-episode schizophrenia spectrum disorders","author":"Luckhoff","year":"2020","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.jad.2024.02.038_bb0265","first-page":"7","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb5170","first-page":"2","article-title":"Use of amisulpride in a psychiatric outpatient clinic in Hong Kong","volume":"14","author":"Mak","year":"2004","journal-title":"Hong Kong J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5190","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1017\/S0033291706007379","article-title":"Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study","volume":"36","author":"Malla","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2024.02.038_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2020.100835","article-title":"Sex bias and omission in neuroscience research is influenced by research model and journal, but not reported NIH funding","volume":"57","author":"Mamlouk","year":"2020","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.jad.2024.02.038_bb0275","first-page":"127","article-title":"Challenges and future prospects of precision medicine in psychiatry","volume":"13","author":"Manchia","year":"2020","journal-title":"Pharmgenomics Pers. Med."},{"key":"10.1016\/j.jad.2024.02.038_bb0280","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12902-022-01135-y","article-title":"The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review","volume":"22","author":"Manosroi","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.jad.2024.02.038_bb0285","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1017\/S1092852912001010","article-title":"Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex","volume":"18","author":"Marazziti","year":"2013","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2024.02.038_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113698","article-title":"Clozapine tolerability in treatment resistant schizophrenia: exploring the role of sex","volume":"297","author":"Martini","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.02.038_bb5175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-1819.2005.01370.x","article-title":"Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non-diabetic Japanese patients with schizophrenia","volume":"59","author":"Matsuda","year":"2005","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.02.038_bb0295","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0021-9258(18)34893-2","article-title":"Estradiol regulates the transcription of the prolactin gene","volume":"257","author":"Maurer","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jad.2024.02.038_bb0300","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.jcp.0000095351.32154.3a","article-title":"Predictors of clinical outcome in schizophrenic patients responding to clozapine","volume":"23","author":"Mauri","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb5195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.schres.2007.10.020","article-title":"Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs","volume":"99","author":"Mauri","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104413","article-title":"Female mice are protected against acute olanzapine-induced hyperglycemia","volume":"110","author":"Medak","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2024.02.038_bb5200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s002130000639","article-title":"Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents","volume":"154","author":"Melkersson","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2024.02.038_bb5205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2125.2001.01352.x","article-title":"Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses","volume":"51","author":"Melkersson","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb5180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0165-1781(83)90001-X","article-title":"Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response","volume":"9","author":"Meltzer","year":"1983","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0310","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0920-9964(01)00326-7","article-title":"Clozapine-induced weight gain predicts improvement in psychopathology","volume":"59","author":"Meltzer","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb5210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.nmd.0000165292.11527.16","article-title":"Incidence of new-onset diabetes mellitus among patients receiving atypical neuroleptics in the treatment of mental illness: evidence from a privately insured population","volume":"193","author":"Miller","year":"2005","journal-title":"J. Nerv. Ment. Des."},{"key":"10.1016\/j.jad.2024.02.038_bb5215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40261-016-0395-x","article-title":"Factors related to early clinical effects of quetiapine extended-release: a multinational, prospective, observational study","volume":"36","author":"Molina","year":"2016","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jad.2024.02.038_bb0315","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archpsyc.1993.01820210057007","article-title":"Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale tardive dyskinesia study","volume":"50","author":"Morgenstern","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00406-011-0235-1","article-title":"The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms","volume":"262","author":"Mossner","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.02.038_bb5225","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archpsyc.1982.04290040064009","article-title":"Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables","volume":"39","author":"Mukherjee","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2006-931540","article-title":"Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study","volume":"39","author":"Muller","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0447.1993.tb03326.x","article-title":"Persistent tardive dyskinesia: demographic and pharmacological risk factors","volume":"87","author":"Muscettola","year":"1993","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.02.038_bb5240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0447.2006.00899.x","article-title":"Weight development in patients treated with risperidone: a 5-year naturalistic study","volume":"115","author":"Neovius","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.02.038_bb0320","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/JCP.0b013e318267b3cd","article-title":"Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish register study","volume":"32","author":"Nielsen","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb0325","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0006-3223(01)01206-9","article-title":"Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders","volume":"51","author":"Obrocea","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5245","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000327602","article-title":"Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia","volume":"64","author":"Olajossy-Hilkesberger","year":"2011","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2024.02.038_bb5250","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4088\/JCP.v64n0913","article-title":"Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol","volume":"64","author":"Oosthuizen","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0330","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jad.2024.02.038_bb0335","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2024.02.038_bb5255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0278-5846(94)90032-9","article-title":"Positive versus negative symptoms in schizophrenia: response to haloperidol","volume":"18","author":"Palao","year":"1994","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"Pt B","key":"10.1016\/j.jad.2024.02.038_bb0340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.nbd.2014.05.011","article-title":"Gender issues in antiepileptic drug treatment","volume":"72","author":"Perucca","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jad.2024.02.038_bb5315","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0920-9964(96)00067-9","article-title":"Lack of gender differences in neuroleptic response in patients with schizophrenia","volume":"22","author":"Pinals","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb5260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.102186","article-title":"Identification of risk factors and metabolic monitoring practices in patients on antipsychotic drugs in South India","volume":"53","author":"Poojari","year":"2020","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jad.2024.02.038_bb5265","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2298\/SARH1512712P","article-title":"Long-term treatment with olanzapine in hospital conditions: prevalence and predictors of the metabolic syndrome","volume":"143","author":"Popovic","year":"2015","journal-title":"Srp. Arh. Celok. Lek."},{"key":"10.1016\/j.jad.2024.02.038_bb5270","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.2147\/NDT.S280719","article-title":"Gender differences in the first-year antipsychotic treatment for Chinese first-episode schizophrenia","volume":"16","author":"Pu","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2024.02.038_bb0345","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2017.03.008","article-title":"Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature","volume":"120","author":"Pucci","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0350","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.4088\/JCP.13m08853","article-title":"Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials","volume":"75","author":"Rabinowitz","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5275","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2006-948327","article-title":"Gender-specific effects in the treatment of acute schizophrenia with risperidone","volume":"39","author":"Raedler","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5280","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF01997715","article-title":"Tardive dystonia. Prevalence, risk factors and clinical features","volume":"17","author":"Raja","year":"1996","journal-title":"Ital. J. Neurol. Sci."},{"issue":"Suppl B","key":"10.1016\/j.jad.2024.02.038_bb0355","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/S1550-8579(07)80056-8","article-title":"Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease","volume":"4","author":"Regitz-Zagrosek","year":"2007","journal-title":"Gend. Med."},{"key":"10.1016\/j.jad.2024.02.038_bb0360","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0706743717720448","article-title":"Guidelines for the pharmacotherapy of schizophrenia in adults","volume":"62","author":"Remington","year":"2017","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2024.02.038_bb0365","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/schbul\/20.1.203","article-title":"Can estradiol modulate schizophrenic symptomatology?","volume":"20","author":"Riecher-R\u00f6ssler","year":"1994","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jad.2024.02.038_bb5285","doi-asserted-by":"crossref","first-page":"CR656-660","DOI":"10.12659\/MSM.883543","article-title":"Screening for the markers of kidney damage in men and women on long-term lithium treatment","volume":"18","author":"Rybakowski","year":"2012","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jad.2024.02.038_bb5290","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archpsyc.1994.03950120035007","article-title":"Clinical characteristics and predisposing factors in acute drug-induced akathisia","volume":"51","author":"Sachdev","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5295","first-page":"1089","article-title":"High risk of metabolic syndrome among black South African women with severe mental illness","volume":"23","author":"Saloojee","year":"2017","journal-title":"S. Afr. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0370","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF02336563","article-title":"Relationship of neuroleptic-induced akathisia to drug-induced parkinsonism","volume":"11","author":"Sandyk","year":"1990","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.jad.2024.02.038_bb5300","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1192\/bjp.143.1.42","article-title":"A review and controlled study of cutaneous conditions associated with lithium carbonate","volume":"143","author":"Sarantidis","year":"1983","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0375","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/YIC.0000000000000250","article-title":"Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics: evidence for the role of alternative pathways apart from CYP1A2","volume":"34","author":"Scherf-Clavel","year":"2019","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb0380","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnoses for tardive dyskinesia","volume":"39","author":"Schooler","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5305","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00406-011-0218-2","article-title":"Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder","volume":"262","author":"Segarra","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.02.038_bb0385","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.numecd.2020.04.034","article-title":"Gender differences in the impact of metabolic syndrome components on mortality in older people: a systematic review and meta-analysis","volume":"30","author":"Sergi","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.jad.2024.02.038_bb0390","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/YIC.0b013e328341e434","article-title":"A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics","volume":"26","author":"Serretti","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb5310","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/a-1353-6544","article-title":"Sex-specific association of antipsychotic-induced weight gain and treatment response for antipsychotic-naive first episode schizophrenia patients: a prospective 8-week longitudinal study","volume":"54","author":"Shi","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0395","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1176\/ajp.156.11.1744","article-title":"Double-blind study of clozapine dose response in chronic schizophrenia","volume":"156","author":"Simpson","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0400","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/070674371005500303","article-title":"The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review","volume":"55","author":"Sinyor","year":"2010","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2024.02.038_bb0405","series-title":"Stahl\u2019s Essential Psychopharmacology: prescriber\u2019s Guide","author":"Stahl","year":"2017"},{"key":"10.1016\/j.jad.2024.02.038_bb0410","article-title":"Gender differences in the response to antipsychotic medication in patients with schizophrenia: an individual patient data meta-analysis of placebo-controlled studies","volume":"320","author":"Storosum","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0415","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/hup.764","article-title":"Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study","volume":"21","author":"Strous","year":"2006","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb0420","series-title":"2020 National Survey of Drug Use and Health (NSDUH)","author":"Substance Abuse and Mental Health Services Administration","year":"2022"},{"key":"10.1016\/j.jad.2024.02.038_bb0425","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1176\/ajp.152.5.698","article-title":"Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients","volume":"152","author":"Szymanski","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0430","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0006-3223(95)00138-7","article-title":"Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics","volume":"39","author":"Szymanski","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0435","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/npr2.12109","article-title":"Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: an analysis of claims data from a Japanese prefecture","volume":"40","author":"Takahashi","year":"2020","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.jad.2024.02.038_bb5320","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2016.09.034","article-title":"Effect of patient age on treatment response in a study of the acute exacerbation of psychosis in schizophrenia","volume":"179","author":"Targum","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0440","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/mds.22707","article-title":"Non-therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: a meta-analysis","volume":"24","author":"Tenback","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2024.02.038_bb5325","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.schres.2012.06.003","article-title":"[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism","volume":"139","author":"Tinazzi","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0445","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jad.2013.01.022","article-title":"Efficacy of olanzapine monotherapy in acute bipolar depression: a pooled analysis of controlled studies","volume":"149","author":"Tohen","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.02.038_bb5330","first-page":"27","article-title":"Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters","volume":"5","author":"Tondo","year":"2017","journal-title":"Int"},{"key":"10.1016\/j.jad.2024.02.038_bb0450","doi-asserted-by":"crossref","unstructured":"Usall, J., Suarez, D., Haro, J.M., Group, S.S., 2007. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry Res. 153, 225\u2013231.","DOI":"10.1016\/j.psychres.2006.09.016"},{"key":"10.1016\/j.jad.2024.02.038_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0149-7634(86)90029-1","article-title":"Effects of estrogen on the basal ganglia","volume":"10","author":"Van Hartesveldt","year":"1986","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2024.02.038_bb5335","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/JGP.0b013e3181c6584e","article-title":"Prevalence and determinants of thyroid disorders in elderly patients with affective disorders: lithium and nonlithium patients","volume":"18","author":"van Melick","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5340","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0447.1997.tb10153.x","article-title":"Tardive dyskinesia: who is at risk?","volume":"96","author":"van Os","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.02.038_bb5345","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1080\/00048670903107609","article-title":"Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis","volume":"43","author":"Verma","year":"2009","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0460","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/JCP.0b013e31820e4832","article-title":"Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion","volume":"31","author":"Veselinovic","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb5350","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1192\/bjpo.bp.116.002691","article-title":"Morbidity and mortality of women and men with intellectual and developmental disabilities newly initiating antipsychotic drugs","volume":"2","author":"Vigod","year":"2016","journal-title":"B. J. Psych. Open"},{"key":"10.1016\/j.jad.2024.02.038_bb0465","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1176\/appi.ajp.157.9.1509","article-title":"Sex differences in response to lithium treatment","volume":"157","author":"Viguera","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0470","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1034\/j.1399-5618.2001.30503.x","article-title":"Response to lithium maintenance treatment in bipolar disorders: comparison of women and men","volume":"3","author":"Viguera","year":"2001","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.02.038_bb0475","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnins.2012.00084","article-title":"A comparative, developmental, and clinical perspective of neurobehavioral sexual dimorphisms","volume":"6","author":"Viveros","year":"2012","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jad.2024.02.038_bb0480","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/acps.13228","article-title":"Impact of smoking behavior on clozapine blood levels - a systematic review and meta-analysis","volume":"142","author":"Wagner","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.02.038_bb5355","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/JCP.0000000000000050","article-title":"Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine","volume":"34","author":"Walther","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb0485","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/pds.1805","article-title":"Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder","volume":"18","author":"Wisniewski","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2024.02.038_bb0490","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15557\/PiPK.2016.0002","article-title":"Clinical assessment of antipsychotic-induced extrapyramidal symptoms in nursing home residents with schizophrenia","volume":"16","author":"Wozniak","year":"2016","journal-title":"Psychiatria i Psychologia Kliniczna"},{"key":"10.1016\/j.jad.2024.02.038_bb0495","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/JCP.0b013e3180cac8db","article-title":"Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia","volume":"27","author":"Wu","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb5360","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/0269881119885260","article-title":"Relationship between metabolic syndrome and acylated\/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication","volume":"34","author":"Wu","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.02.038_bb5365","first-page":"314","article-title":"The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review","volume":"24","author":"Wysokinski","year":"2012","journal-title":"Psychiatr"},{"key":"10.1016\/j.jad.2024.02.038_bb5370","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.psychres.2010.03.014","article-title":"Sex differences in patients with schizophrenia: a prospective, multi-center study","volume":"177","author":"Xiang","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.02.038_bb5375","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00213-018-5107-1","article-title":"Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia","volume":"236","author":"Yang","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2024.02.038_bb0500","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/schbul\/18.4.701","article-title":"Gender differences in tardive dyskinesia: a critical review of the literature","volume":"18","author":"Yassa","year":"1992","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jad.2024.02.038_bb0505","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1176\/ajp.147.9.1156","article-title":"Factors in the development of severe forms of tardive dyskinesia","volume":"147","author":"Yassa","year":"1990","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb0510","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.02.038_bb5380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4088\/JCP.v59n0106","article-title":"Clinical predictors of acute response with olanzapine in psychotic mood disorders","volume":"59","author":"Zarate","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.038_bb5385","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00213-009-1590-8","article-title":"Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia","volume":"205","author":"Zhang","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2024.02.038_bb0515","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jpsychires.2010.02.015","article-title":"Sex difference in the prevalence of smoking in Chinese schizophrenia","volume":"44","author":"Zhang","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"8","key":"10.1016\/j.jad.2024.02.038_bb5390","article-title":"Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jad.2024.02.038_bb0520","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0165-1781(98)00114-0","article-title":"An investigation of ethnic and gender differences in the pharmacodynamics of haloperidol","volume":"81","author":"Zhang-Wong","year":"1998","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.02.038_bb0525","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/0101-60830000000189","article-title":"Sex-differential effects of olanzapine vs. aripiprazole on glucose and lipid metabolism in first-episode schizophrenia","volume":"46","author":"Zhou","year":"2019","journal-title":"Revista de Psiquiatria Clinica"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724003471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724003471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:12:09Z","timestamp":1781928729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724003471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":180,"alternative-id":["S0165032724003471"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.02.038","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in effectiveness and adverse effects of mood stabilizers and antipsychotics: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}